Janssen and Genmab hope for repeat success with next-gen agreement
Genmab agrees deal with Janssen to develop a next-generation mAb product in oncology, which looks to build on the commercial success of the companies’ partnership on Darzalex.
Archives for June 12, 2019
Vertex strikes two deals to double down on gene therapy
Vertex agrees to acquire Exonics and to expand its collaboration with CRISPR Therapeutics, which sees it invest $420m in upfront payments to develop its position in gene therapy.